Mass General Brigham

Healis Therapeutics announces collaboration with Massachusetts General Hospital (MGH) and affiliates of Harvard Medical School to advance clinical-stage neuroscience research

Retrieved on: 
Tuesday, March 26, 2024
MGH, Harvard Medical School, Public health, Mass General Brigham, Massachusetts General Hospital, MDD, Patient, Public, Roche, Research, Merck, Social anxiety disorder, DSM-IV codes, Bristol Myers Squibb, Clinical trial, Neuropsychiatry, HMS, World Health Organization, Therapy, Hospital, Safety, WHO, SAD, Major depressive disorder, PTSD, Mass, Pharmaceutical industry

Healis Therapeutics is pleased to announce that it has entered a clinical collaboration with Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health system, and affiliates of Harvard Medical School (HMS).

Key Points: 
  • Healis Therapeutics is pleased to announce that it has entered a clinical collaboration with Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health system, and affiliates of Harvard Medical School (HMS).
  • “We continue to observe very significant need in the neuropsychiatric patient population,” said Dr. Eric Finzi, Co-Founder of Healis Therapeutics.
  • “MDD remains a public health challenge around the world,” said Erik Van Widenfelt, Head of Clinical Trials at Healis Therapeutics.
  • General Hospital (MGH) and Harvard Medical School,” said Sebastian De Beurs, Co-Founder of Healis Therapeutics.

NeuroCatch Introduces PeakSelect, Enabling a Deeper Clinical Dive into Brain Vital Signs at a Doctor's Office Near You

Retrieved on: 
Tuesday, April 9, 2024
Research, MD–PhD, Blood pressure, Neurology, Brain, Concussion, Mass General Brigham, Vital signs, Clinical, Neuro, Patient, Mental health, Thermoregulation, MD, Athlete, Medicine, Detroit Lions, Dementia, Sport, ERPs, Medical device

BOSTON, April 9, 2024 /PRNewswire/ -- NeuroCatch Inc., a leading medical device company that enables rapid access to an objective assessment of brain health at the point of care, today announced the release of PeakSelect, an innovative software tool designed to improve clinical decision making. An enhancement to the NeuroCatch Platform, PeakSelect allows users to evaluate specific brain vital sign responses for precision medicine in patients undergoing portable neuro-physiological brain function assessment.

Key Points: 
  • An enhancement to the NeuroCatch Platform, PeakSelect allows users to evaluate specific brain vital sign responses for precision medicine in patients undergoing portable neuro-physiological brain function assessment.
  • "The first of an ongoing cadence of planned software upgrades, PeakSelect enhances the impact of NeuroCatch's brain health vital sign data to inform better clinical decision-making, more robust clinical trials, and more effective training regimes."
  • Through regular, over-the-air updates, NeuroCatch is continually advancing the powerful impact of brain vital sign monitoring for frontline health impacts.
  • "The NeuroCatch platform has already proven itself a breakthrough device with its mobile ability, rapid analysis and sophisticated sensitivity to analyze brain vital sign data.

Two Pediatric Medical Device Companies Receive Prestigious Award at MedTech Color Edition of Make Your Medical Device Pitch For Kids!™ Competition

Retrieved on: 
Monday, March 18, 2024
Pigment, Government, Mass General Brigham, Partnership, Risk, Patient, Research, African Americans, University, Pulse, Johns Hopkins University, Skin, Hospital, Community engagement, Ecosystem, Tufts Medical Center, Food, Blood, FDA, Medtech, Nursing

The event was held on March 15 at the University of California, Los Angeles, as part of the annual MedTech Color Pitch Competition during L.A. MedTech Week 2024, powered by BioscienceLA.

Key Points: 
  • The event was held on March 15 at the University of California, Los Angeles, as part of the annual MedTech Color Pitch Competition during L.A. MedTech Week 2024, powered by BioscienceLA.
  • The award-winning pediatric devices and companies are:
    Rubitection, Pittsburgh, Pa.– A low-cost skin assessment management tool for chronic wounds, Rubitection measures the properties of the skin.
  • – This patent-pending pulse oximeter device is designed specifically for pediatric populations to provide superior accuracy for all levels of skin pigmentation.
  • Advancements in pediatric medical devices continue to lag significantly behind those of adults, which is why APDI is focused on helping more pediatric medical device innovations achieve commercialization.

Insights on Leading Employers in Top Business Sectors and Insurers that Serve Them by Mark Farrah Associates

Retrieved on: 
Monday, March 25, 2024
Public Policy, Government, Insurance, Finance, General Health, Health, Healthcare Reform, Banking, Professional Services, Blue Shield, Fashion merchandising, Welfare, Retail, Walmart, MFA, Internal Revenue Service, UPMC, Mass General Brigham, ERISA, Average revenue per user, Health care, Mass, Health insurance

Mark Farrah Associates (MFA), www.markfarrah.com , presents a high-level analysis of the leading employers in top business sectors, as well as the key health benefit insurers that serve them, utilizing information from MFA’s 5500 Employer Health Plus product.

Key Points: 
  • Mark Farrah Associates (MFA), www.markfarrah.com , presents a high-level analysis of the leading employers in top business sectors, as well as the key health benefit insurers that serve them, utilizing information from MFA’s 5500 Employer Health Plus product.
  • Large private-sector employers providing health and welfare benefit plans subject to ERISA are required to file the annual Form 5500 with the Internal Revenue Service.
  • Observations obtained from 5500 Employer Health Plus are based on 86,200 employers that indicated they had active health benefit contracts as of their most recent filings.
  • Private-sector employers reported 89.7 million potential plan participants across the spectrum of all health benefit contracts.

GE HealthCare and Mass General Brigham Evolve Their AI Collaboration with Medical Imaging Foundation Models

Retrieved on: 
Tuesday, March 12, 2024
Radiology, Pharmaceutical, General Health, Health, Artificial Intelligence, Hospitals, Health Technology, Technology, Organization, Mass General Brigham, Partnership, Patient, Research, Artificial intelligence, AI, Mass, Massachusetts General Hospital, GE HealthCare, Patient safety, Privacy, Medical device

Based on its long-term artificial intelligence (AI) partnership, GE HealthCare and Mass General Brigham plan to integrate medical imaging foundation models into their AI research work, with a strong focus on responsible AI practices.

Key Points: 
  • Based on its long-term artificial intelligence (AI) partnership, GE HealthCare and Mass General Brigham plan to integrate medical imaging foundation models into their AI research work, with a strong focus on responsible AI practices.
  • “The relationship between Mass General Brigham’s commercial AI business (Mass General Brigham AI) and GE HealthCare has helped accelerate the introduction of AI into a range of product offerings and digital health solutions.
  • Foundation models have emerged as a reliable and adaptable foundation for developing AI applications tailored to the healthcare sector.
  • “GE HealthCare and Mass General Brigham have a long-standing AI collaboration that has produced AI-powered tools which help increase operational effectiveness and productivity.

Implantable Brain-Computer Interface Collaborative Community (iBCI-CC) to Drive Innovation in Neurotechnology

Retrieved on: 
Monday, March 11, 2024
Research, Other Health, Medical Devices, Hospitals, Health Technology, Surgery, Clinical Trials, Science, Neurology, Biotechnology, FDA, Health, Other Science, Device, DSM-IV codes, Harvard Medical School, BCI, Organization, Mass General Brigham, CDRH, Communication, Massachusetts General Hospital, ALS, Nervous system, Patient, Neurotechnology, Jennifer French, Neuroscience, Friends, Software, Doctor of Philosophy, Master of Science, MBA, Hospital, Physical disability, Safety, Ecosystem, Family, Mass, Food

Mass General Brigham is establishing the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC).

Key Points: 
  • Mass General Brigham is establishing the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC).
  • This is the first Collaborative Community in the clinical neurosciences that has participation from the U.S. Food and Drug Administration (FDA).
  • BCIs are devices that interface with the nervous system and use software to interpret neural activity.
  • This collaborative effort aims to propel the field of iBCIs forward by employing harmonized approaches that drive continuous innovation and ensure equitable access to these transformative technologies.

CodaMetrix Announces $40M Series B Financing to Advance Medical Coding Quality and Clinically Enrich Claims Data Through AI

Retrieved on: 
Tuesday, March 12, 2024
General Health, Health, Data Management, Technology, Artificial Intelligence, Organization, Mass General Brigham, Entrepreneurship, Partner (business rank), Acceleration, Artificial intelligence, GI, Radiology, University, Pathology, Mount Sinai Health System, Mass, Emerge Commerce, Medical device

Transformation Capital led the financing with continued support from existing investors SignalFire, Series A lead, and Frist Cressey Ventures.

Key Points: 
  • Transformation Capital led the financing with continued support from existing investors SignalFire, Series A lead, and Frist Cressey Ventures.
  • Series B financing will be used to further advance CodaMetrix’s AI-powered solutions which improve medical coding quality, produce clinically comprehensive data sets, reduce the overall cost of care, and alleviate administrative burden on providers.
  • “Medical coding is one of the most time-consuming, understaffed and inherently error-prone parts of the health system revenue cycle.
  • “Our game changing AI platform delivers vital automation which not only addresses these pain points but, more significantly, changes claims data from notoriously unreliable to clinically valuable.

Behavioral Health Industry Experts Join Oceans Healthcare's Board of Directors

Retrieved on: 
Thursday, March 21, 2024
Acumen, Harvard Medical School, Child and adolescent psychiatry, Partner, Psychiatry, Communication, Massachusetts General Hospital, Partnership, COVID-19, Patient, Mass General Brigham, Knowledge, Child, Human services, Adolescence, Pediatrics, Medicaid, Hospital, Medicare, Policy, Legislation, Nursing

PLANO, Texas, March 21, 2024 /PRNewswire/ -- Oceans Healthcare has announced the addition of highly regarded Harvard Medical School psychiatry professor Dr. Michael Jellinek and decorated public health executive Dr. Courtney Phillips to its Board of Directors. These additions underscore the growing behavioral health organization's commitment to advancing healing and long-term recovery through patient-centered behavioral health care.

Key Points: 
  • These additions underscore the growing behavioral health organization's commitment to advancing healing and long-term recovery through patient-centered behavioral health care.
  • "Our nation's behavioral health crisis demands leaders with a breadth of knowledge and unwavering compassion," said Oceans Healthcare CEO Stuart Archer.
  • "Effective communication, alongside advocating for legislation that supports patients and health care providers, is crucial in informing stakeholders about the intricate nature and continuum of behavioral health services," Phillips emphasized.
  • Through acquisitions, high-profile joint ventures, new facility development and the addition of new services, Oceans has grown 300% since 2014.

Microsoft and NVIDIA announce major integrations to accelerate generative AI for enterprises everywhere

Retrieved on: 
Monday, March 18, 2024
Cloud, Microsoft, Sanofi, Microsoft Azure, GTC, Organization, Natural language processing, GPU, Triton, Broad Institute, Public health, Biotechnology, Mass General Brigham, MIT, InfiniBand, Harvard University, SAN, MIG, 3D, Microsoft Power BI, AI, University, First officer (aviation), Software, GENETICS, AUC, VM, LLM, Cloud computing, VMS, Creativity, NIM, Flywheel, NVIDIA, Health, Mass, Silicon, Video game

New NVIDIA generative AI Microservices for enterprise, developer and healthcare applications coming to Microsoft Azure AI

Key Points: 
  • New NVIDIA generative AI Microservices for enterprise, developer and healthcare applications coming to Microsoft Azure AI
    REDMOND, Wash. and SAN JOSE, Calif., March 18, 2024 /PRNewswire/ -- At GTC on Monday, Microsoft Corp. and NVIDIA expanded their longstanding collaboration with powerful new integrations that leverage the latest NVIDIA generative AI and Omniverse™ technologies across Microsoft Azure, Azure AI services, Microsoft Fabric and Microsoft 365.
  • "AI is transforming our daily lives — opening up a world of new opportunities," said Jensen Huang, founder and CEO of NVIDIA.
  • At NVIDIA GTC , Microsoft is demonstrating a preview of what is possible using Omniverse Cloud APIs on Microsoft Azure.
  • NVIDIA GPUs and NVIDIA Triton Inference Server™ help serve AI inference predictions in Microsoft Copilot for Microsoft 365.

New consortium of healthcare leaders announces formation of Trustworthy & Responsible AI Network (TRAIN), making safe and fair AI accessible to every healthcare organization

Retrieved on: 
Monday, March 11, 2024
Informatics, Algorithm, Responsibility, Information technology, Health, Biomedical Research, Patient, Cleveland Clinic, Approximation error, Artificial intelligence in healthcare, Microsoft, Public, AdventHealth, Mass General Brigham, Coalition, Science, Policy, Safety, Boston Children's Hospital, VUMC, Organization, Bias, Trust (social science), Research, AI, University, Nouvelle AI, MPH, Vanderbilt University Medical Center, Hospital, Sharp HealthCare, Internal medicine, Health informatics, Conference, Public health, Cardiology, Caregiver, MedStar Health, CHAI, HIMSS, Mount Sinai Health System, Medical device

New AI capabilities have the potential to transform the healthcare industry by enabling better care outcomes, improving efficiency and productivity, and reducing costs.

Key Points: 
  • New AI capabilities have the potential to transform the healthcare industry by enabling better care outcomes, improving efficiency and productivity, and reducing costs.
  • Enabling registration of AI used for clinical care or clinical operations through a secure online portal.
  • "By working together, TRAIN members aim to establish best practices for operationalizing responsible AI, helping improve patient outcomes and safety while fostering trust in healthcare AI."
  • "We are excited to join our TRAIN partners in the journey to accelerate AI innovation in an ethical, responsible and safe way."